Yi Tao

1.4k citations
87 papers · 1.1k indexed · h-index 18
Topics
Natural product bioactivities and synthesis (27 papers)Metabolomics and Mass Spectrometry Studies (14 papers)Traditional Chinese Medicine Analysis (14 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Yi Tao

82 papers receiving 1.1k citations

Peers

Yi Tao
Comparison fields: 5 of 106
  • Molecular Biology 562
  • Pharmacology 263
  • Plant Science 256
  • Pharmacology 244
  • Complementary and alternative medicine 209
Replace Guangtong Chen with:
Guangtong Chen China
Zhongxiang Zhao China
Peiying Shi China
Chenchen Zhu China
Guixiang Pan China
Hai Jiang China
Yun Huang China
Kate Yu United States
Qingfa Tang China
Yueping Jiang China
Yi Tao relative to Guangtong Chen China Guangtong Chen's profile →
Citations per field
00.5×1.5×2.5×
Guangtong Chen · 1×
Citations per year

Countries citing papers authored by Yi Tao

Since Specialization
Citations

This map shows the geographic impact of Yi Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Tao more than expected).

Fields of papers citing papers by Yi Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Tao. The network helps show where Yi Tao may publish in the future.

Co-authorship network of co-authors of Yi Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Tao. A scholar is included among the top collaborators of Yi Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Tao. Yi Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 1
5 1
6 3
7 4
8 12
9 18
10 3
11 30
12 22
13 16
14
ラット血しょう中のフラボノイド8種の同時定量のためのUPLC‐MS/MS法とラットにおけるFu Zhu Jiang Tang錠の薬物動力学研究への応用【Powered by NICT】
1
15 25
16 5
17 52
18 54
19 2
20 35

About Yi Tao

Yi Tao is a scholar working on Complementary and alternative medicine, Pharmacology and Pharmacology, having authored 87 papers that have together received 1.1k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (27 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Traditional Chinese Medicine Analysis (14 papers). The work is most often cited by research in Pharmacology (263 citations), Complementary and alternative medicine (209 citations) and Pharmacology (244 citations). Yi Tao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Baochang Cai, Weidong Li, Jizhong Yan, Richard B. van Breemen, Yiyu Cheng, Yì Wáng, Yufeng Zhang, Hao Cai, Wenkui Li and Wenzhong Liang. Their work appears in journals such as Chemical Communications, Journal of Agricultural and Food Chemistry and Journal of Chromatography A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026